A Meta-analysis of Immune Parameters, Variability, and Assessment of Modal Distribution in Psychosis and Test of the Immune Subgroup Hypothesis.


Journal

Schizophrenia bulletin
ISSN: 1745-1701
Titre abrégé: Schizophr Bull
Pays: United States
ID NLM: 0236760

Informations de publication

Date de publication:
11 09 2019
Historique:
pubmed: 9 11 2018
medline: 11 7 2020
entrez: 9 11 2018
Statut: ppublish

Résumé

Immune parameters are elevated in psychosis, but it is unclear whether alterations are homogenous across patients or heterogeneity exists, consistent with the hypothesis that immune alterations are specific to a subgroup of patients. To address this, we examine whether antipsychotic-naïve first-episode psychosis patients exhibit greater variability in blood cytokines, C-reactive protein, and white cell counts compared with controls, and if group mean differences persist after adjusting for skewed data and potential confounds. Databases were searched for studies reporting levels of peripheral immune parameters. Means and variances were extracted and analyzed using multivariate meta-analysis of mean and variability of differences. Outcomes were (1) variability in patients relative to controls, indexed by variability ratio (VR) and coefficient of variation ratio (CVR); (2) mean differences indexed by Hedges g; (3) Modal distribution of raw immune parameter data using Hartigan's unimodality dip test. Thirty-five studies reporting on 1263 patients and 1470 controls were included. Variability of interleukin-6 (IL6) (VR = 0.19), tumor necrosis factor-α (TNFα) (VR = 0.36), interleukin-1β (VR = 0.35), interleukin-4 (VR = 0.55), and interleukin-8 (VR = 0.28) was reduced in patients. Results persisted for IL6 and IL8 after mean-scaling. Ninety-four percent and one hundred percent of raw data were unimodally distributed in psychosis and controls, respectively. Mean levels of IL6 (g = 0.62), TNFα (g = 0.56), interferon-γ (IFNγ) (g = 0.32), transforming growth factor-β (g = 0.53), and interleukin-17 (IL17) (g = 0.48) were elevated in psychosis. Sensitivity analyses indicated this is unlikely explained by confounders for IL6, IFNγ, and IL17. These findings show elevated cytokines in psychosis after accounting for confounds, and that the hypothesis of an immune subgroup is not supported by the variability or modal distribution.

Identifiants

pubmed: 30407606
pii: 5164363
doi: 10.1093/schbul/sby160
pmc: PMC6737479
mid: EMS82490
doi:

Substances chimiques

CXCL8 protein, human 0
Cytokines 0
IFNG protein, human 0
IL1B protein, human 0
IL4 protein, human 0
IL6 protein, human 0
Interleukin-17 0
Interleukin-1beta 0
Interleukin-6 0
Interleukin-8 0
TNF protein, human 0
Transforming Growth Factor beta 0
Tumor Necrosis Factor-alpha 0
Interleukin-4 207137-56-2
Interferon-gamma 82115-62-6
C-Reactive Protein 9007-41-4

Types de publication

Journal Article Meta-Analysis Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1120-1133

Subventions

Organisme : Medical Research Council
ID : MC_U120097115
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 200102/Z/15/Z
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC-A656-5QD30
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 094849/Z/10/Z
Pays : United Kingdom

Informations de copyright

© The Author(s) 2018. Published by Oxford University Press on behalf of the Maryland Psychiatric Research Center.

Références

Schizophr Res. 2001 Jan 15;47(1):13-25
pubmed: 11163541
Cancer Epidemiol Biomarkers Prev. 2010 Apr;19(4):978-81
pubmed: 20332253
J Clin Epidemiol. 2009 Oct;62(10):1006-12
pubmed: 19631508
Schizophr Res. 2014 May;155(1-3):101-8
pubmed: 24704219
J Gerontol A Biol Sci Med Sci. 2014 Jun;69 Suppl 1:S4-9
pubmed: 24833586
Psychiatry Res. 2011 Nov 30;190(1):91-7
pubmed: 21621854
Bioanalysis. 2013 Jan;5(2):245-64
pubmed: 23330564
Nature. 2006 May 11;441(7090):235-8
pubmed: 16648838
Psychiatry Res. 2005 Apr 15;134(2):151-9
pubmed: 15840416
Brain Behav Immun. 2013 Jul;31:90-5
pubmed: 22749891
Arch Gen Psychiatry. 1989 Mar;46(3):292
pubmed: 2784048
PLoS One. 2012;7(10):e46423
pubmed: 23110049
Front Pharmacol. 2017 Mar 20;8:139
pubmed: 28373844
Biol Psychiatry. 2008 Apr 15;63(8):801-8
pubmed: 18005941
Glia. 2006 Jan 15;53(2):212-24
pubmed: 16206168
Science. 2011 Sep 9;333(6048):1456-8
pubmed: 21778362
Mol Biol Rep. 2013 Oct;40(10):5607-14
pubmed: 24065520
Biochim Biophys Acta. 2011 May;1813(5):878-88
pubmed: 21296109
Mol Neurobiol. 2016 Oct;53(8):5701-9
pubmed: 26491028
Schizophr Bull. 2018 Jan 13;44(1):75-83
pubmed: 28338954
Front Neurosci. 2015 Oct 21;9:372
pubmed: 26539073
Clin Schizophr Relat Psychoses. 2014 Jan;7(4):223-30
pubmed: 23428789
Br J Psychiatry. 2014 Jul;205(1):1-3
pubmed: 24986384
J Immunol. 1988 Sep 1;141(5):1543-9
pubmed: 3261754
Epidemiol Rev. 2008;30:67-76
pubmed: 18480098
Eur J Epidemiol. 2010 Sep;25(9):603-5
pubmed: 20652370
Neuropsychopharmacology. 2018 May;43(6):1317-1323
pubmed: 29090685
PLoS One. 2014 May 02;9(5):e96021
pubmed: 24787542
J Child Adolesc Psychopharmacol. 2016 Oct;26(8):721-726
pubmed: 27384868
Mol Psychiatry. 2016 Apr;21(4):554-64
pubmed: 26169974
JAMA Psychiatry. 2017 Mar 1;74(3):261-269
pubmed: 28097367
Neurosci Lett. 1999 Aug 20;271(2):126-8
pubmed: 10477118
J Psychiatr Res. 2012 Nov;46(11):1421-6
pubmed: 22974591
Biol Psychiatry. 2011 Oct 1;70(7):663-71
pubmed: 21641581
Mol Psychiatry. 2016 Dec;21(12):1696-1709
pubmed: 26903267
Schizophr Res. 2015 May;164(1-3):53-8
pubmed: 25716958
Acta Physiol (Oxf). 2008 Jan;192(1):37-48
pubmed: 18171428
Transl Psychiatry. 2017 Feb 7;7(2):e1024
pubmed: 28170004
Biol Psychiatry. 2009 Mar 15;65(6):481-8
pubmed: 19058794
Psychiatry Res. 1994 Jan;51(1):1-10
pubmed: 7910974
Schizophr Res. 2009 Feb;107(2-3):122-7
pubmed: 19046857
J Neuroinflammation. 2017 Sep 18;14(1):188
pubmed: 28923068
Nature. 2014 Jul 24;511(7510):421-7
pubmed: 25056061
Schizophr Res. 1992 Mar;6(3):237-41
pubmed: 1571315
J Clin Epidemiol. 2008 Sep;61(9):857-65
pubmed: 18687287
J Clin Psychiatry. 2016 Feb;77(2):275-6
pubmed: 26930525
Asian J Psychiatr. 2016 Dec;24:99-102
pubmed: 27931919
Schizophr Res. 2014 Jun;156(1):9-14
pubmed: 24766914
Blood. 1989 Sep;74(4):1241-4
pubmed: 2788464
Prog Neuropsychopharmacol Biol Psychiatry. 2014 Jun 3;51:78-82
pubmed: 24447943
Schizophr Res. 2015 Aug;166(1-3):225-30
pubmed: 26123170
Acta Psychiatr Scand. 1994 Nov;90(5):311-5
pubmed: 7872033
J Intern Med. 2007 Oct;262(4):408-14
pubmed: 17875176
Schizophr Res. 1999 Jul 27;38(1):61-70
pubmed: 10427611
Am J Psychiatry. 2016 Apr 1;173(4):373-84
pubmed: 26651391
Methods Mol Biol. 2009;511:107-42
pubmed: 19347295
Early Interv Psychiatry. 2019 Feb;13(1):101-109
pubmed: 28719155
Psychiatr Danub. 2012 Sep;24 Suppl 1:S153-6
pubmed: 22945211
Schizophr Res. 2013 Oct;150(1):269-73
pubmed: 23968860
Mucosal Immunol. 2009 Sep;2(5):403-11
pubmed: 19587639
Am J Psychiatry. 2017 Mar 1;174(3):216-229
pubmed: 27919182
Psychol Med. 2012 Sep;42(9):1893-901
pubmed: 22260948
BMJ. 1996 Nov 9;313(7066):1200
pubmed: 8916759
Mol Psychiatry. 2019 Jun;24(6):776-794
pubmed: 29743584
Schizophr Res. 2015 Dec;169(1-3):22-29
pubmed: 26364730
Ann N Y Acad Sci. 2012 Jul;1261:55-63
pubmed: 22823394
Biol Psychiatry. 2014 Feb 15;75(4):300-6
pubmed: 24199668
Clin Chem. 2003 Apr;49(4):669-72
pubmed: 12651827
Psychiatry Res. 2015 Jan 30;225(1-2):58-63
pubmed: 25453636
Br J Psychiatry. 2009 May;194(5):434-8
pubmed: 19407273
JAMA. 2000 Apr 19;283(15):2008-12
pubmed: 10789670
Early Interv Psychiatry. 2009 Nov;3(4):259-65
pubmed: 22642728
Am J Psychiatry. 2016 Jan;173(1):44-52
pubmed: 26472628
J Clin Invest. 2003 Aug;112(4):598-607
pubmed: 12925700
Neurosci Lett. 1994 Sep 26;179(1-2):53-6
pubmed: 7845624
J Neuropathol Exp Neurol. 2000 Feb;59(2):137-50
pubmed: 10749103
Transl Psychiatry. 2017 May 9;7(5):e1121
pubmed: 28485731
Psychopharmacology (Berl). 2014 Jan;231(2):319-25
pubmed: 24337064
Mol Psychiatry. 2016 Aug;21(8):1090-8
pubmed: 26194183
J Psychiatr Res. 2000 Nov-Dec;34(6):369-82
pubmed: 11165304
J Clin Invest. 2005 Jan;115(1):66-75
pubmed: 15630445
Shock. 2010 Mar;33(3):258-62
pubmed: 19543152
Asian J Psychiatr. 2017 Apr;26:99-103
pubmed: 28483103
J Bone Miner Res. 1996 Jan;11(1):88-95
pubmed: 8770701
Am J Psychiatry. 2011 Dec;168(12):1303-10
pubmed: 22193673
Transl Psychiatry. 2018 Jun 6;8(1):112
pubmed: 29875399
JAMA Psychiatry. 2017 Nov 1;74(11):1104-1111
pubmed: 28973084
Br J Psychiatry. 2017 Dec;211(6):339-349
pubmed: 28982658
Schizophr Res. 1999 May 4;37(1):97-106
pubmed: 10227112
Acta Neuropathol. 2006 Sep;112(3):305-16
pubmed: 16783554
Eur J Immunol. 2010 Jul;40(7):1830-5
pubmed: 20583029
Schizophr Bull. 2015 Sep;41(5):1162-70
pubmed: 25829375
Ethn Dis. 2011 Spring;21(2):142-9
pubmed: 21749016
Early Interv Psychiatry. 2019 Feb;13(1):95-100
pubmed: 28786532
Schizophr Res. 1990 Jul-Aug;3(4):269-75
pubmed: 1980614
J Psychosom Res. 2015 Oct;79(4):324-7
pubmed: 26213351
Psychol Med. 2011 Jun;41(6):1127-31
pubmed: 20810003
J Neurosci Res. 2000 Jul 1;61(1):10-20
pubmed: 10861795
Adv Health Sci Educ Theory Pract. 2011 Aug;16(3):291-6
pubmed: 21400008
Chest. 2007 May;131(5):1557-66
pubmed: 17494805
Schizophr Res. 2016 Oct;176(2-3):431-440
pubmed: 27261419
N Engl J Med. 2000 May 4;342(18):1350-8
pubmed: 10793168
Psychopharmacology (Berl). 2016 May;233(9):1637-50
pubmed: 26847047
Arch Gen Psychiatry. 1995 Aug;52(8):668-72
pubmed: 7632120
Psychol Med. 2019 Oct;49(13):2186-2196
pubmed: 30355368
Annu Rev Immunol. 2006;24:99-146
pubmed: 16551245
Psychol Med. 1999 May;29(3):697-701
pubmed: 10405091
J Psychopharmacol. 2015 Feb;29(2):97-115
pubmed: 25586400
Iran J Immunol. 2014 Sep;11(3):200-9
pubmed: 25265997
Glia. 1997 Mar;19(3):227-33
pubmed: 9063729
Biol Psychiatry. 2013 May 15;73(10):993-9
pubmed: 23062357
JAMA. 1999 Dec 8;282(22):2131-5
pubmed: 10591334
BMJ. 2003 Sep 6;327(7414):557-60
pubmed: 12958120

Auteurs

Toby Pillinger (T)

Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.

Emanuele F Osimo (EF)

Department of Psychiatry, University of Cambridge, Cambridge, UK.
Cambridgeshire and Peterborough NHS Foundation Trust, Cambridge, UK.
Institute of Clinical Sciences, Faculty of Medicine, Imperial College London, London, UK.

Stefan Brugger (S)

Institute of Clinical Sciences, Faculty of Medicine, Imperial College London, London, UK.
Medical Research Council London Institute of Medical Sciences, London, UK.
Division of Psychiatry, University College London, London, UK.

Valeria Mondelli (V)

Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
National Institute for Health Research (NIHR) Mental Health Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London, London, UK.

Robert A McCutcheon (RA)

Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
Institute of Clinical Sciences, Faculty of Medicine, Imperial College London, London, UK.
Medical Research Council London Institute of Medical Sciences, London, UK.

Oliver D Howes (OD)

Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
Institute of Clinical Sciences, Faculty of Medicine, Imperial College London, London, UK.
Medical Research Council London Institute of Medical Sciences, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH